-
Two technologies of Zhonglan Lianhai were selected into the national directory
Time of Update: 2022-09-07
"Phosphate Mine Full Tailings Filling Mining Technology" and "Medium and Low Grade Glue Phosphate Ore Removal Iron and Aluminum Magazine Mineral Processing Technology" were selected into the "Catalogue of Advanced Applicable Technologies for Mineral Resources Conservation and Comprehensive Utilization (2022 Edition)".
-
First imitation
Time of Update: 2022-05-21
During the whole process of preoperative anesthesia, intraoperative sleep, and postoperative awakening, three types of drugs, such as sedatives, analgesics, and muscle relaxants, are usually required to act synergistically, and to reverse the patient's functional state in a timely manner .
-
In this pharmaceutical company, 23 drugs have been withdrawn from the Internet
Time of Update: 2022-05-02
Recently, a notice issued by the Shaanxi Provincial Public Resource Trading Center on the adjustment of the product listing catalogue for the dynamic adjustment of pharmaceutical products on the Internet shows that a total of 57 drugs have been adjusted this time, of which 7 are included in the direct listing catalogue, and the listings are revoked.
-
Metz Tumor Progress Express (Issue 018
Time of Update: 2021-09-03
Another choice for patients with small liver cancer!Recently, published in a journal Radiology Research at a switching unipolar mode, evaluated using a separable clusters electrode non-contact clinical RFA treatment of small HCC (2.
-
Stilla Technologies launches a new reagent product line--naica
Time of Update: 2021-08-08
Stilla Technologies launched a new reagent product line-naica ® dPCR Mixes in November 2020 for digital PCR analysis . In order to improve detection efficiency and higher detection sensitivity, a PC
-
JNNP: Effects of oral food properties on inhalation and swallowing dynamics in patients treated with DBS
Time of Update: 2020-12-23
V2 group had more frequent inhalation (OR 1.71, p-0.019) and more frequent penetration and suction (OR 1.68, p-0.009) than V1, and no significant differences were found in the swallowing parameters of MBSImP and FOIS under DBS conditions in any visit.
-
Week 31 part of Lysine manufacturers to raise external quotations
Time of Update: 2020-06-29
this week: Higer manufacturer siline price 98 lysine 8.5 yuan / kg, 70 lysine 5.5 yuan / kg uMX Plum factory price 98 lysine 8.5 yuan / kg, 70 lysine 5.5 yuan / kg uMX COFCO manufacturers quote 98 lysine 8.5 yuan / kg, 70 lysine 5.5 yuan / kg uMX Gold corn manufacturers quote 98 lysine 8.0 yuan / kg, 70 lysine 5.3 yuan / kg uMX Short comment: quote supther, transaction unchanged, upstream high-quoted low go what kind?
-
New low-toxic candidate drug PTC596 is expected to treat pancreatic cancer
Time of Update: 2020-06-02
Pancreatic cancer is one of the most lethal types of cancer, and pancreatic tumors are supplemented with a thick layer of connective tissue (matrix, stroma), which hardens the tumor and provides prote
-
First line treatment of NSCLC with cindilimab combined with chemotherapy reached the main end point
Time of Update: 2020-01-14
January 13, 2020 / Meitong news agency / -- Xinda biopharmaceutical, a biopharmaceutical company dedicated to the research, development, production and sale of innovative drugs for the treatment of ma
-
What changes have been brought about by the three major reform directions of the new drug price policy
Time of Update: 2019-07-22
have not yet found openings to exploit! The era of low profit of generic drugs will officially come! Recently, the office of the State Medical Insurance Bureau, together with the national development
-
There is hope for the development of new antibiotics
Time of Update: 2014-07-08
Our reporter (Xiong Yan) learned from Kunming Institute of zoology, Chinese Academy of Sciences that the researchers studied the antibacterial peptide of king cobra venom, and found that the ability o
